|
Immuno Chemistry Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017
|
|||||||||||
| Preis** (Lieferformat): |
Versandkostenfrei ** WICHTIG: Alle Preise sind netto ausgewiesen. Abhängig von Versand- und Leistungsort ist hierauf noch USt. zu entrichten (Deutschland z.Z. 19%). Der korrekte Gesamtendpreis wird Ihnen mit der Angabe Ihrer Rechnungsadresse, USt-ID-Nr. etc. im Bestellverlauf ausgewiesen. Weitere Informationen zu den Bestandteilen des Kaufpreises finden Sie in unseren FAQs. |
Zahlen und Fakten zur Studie: | 248 seiten | |||||||||
| Inhalt der Studie: |
Introduction
GlobalData’s new report, “Immuno Chemistry Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017” provides key market data on the Immuno Chemistry market in the BR.....
Introduction GlobalData’s new report, “Immuno Chemistry Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017” provides key market data on the Immuno Chemistry market in the BRICS countries. The report provides value ($m) data for each segment and sub-segment within nine market categories – Disease Specific Immunochemistry, Endocrinology Tests, Immunochemistry Rapid Tests, Immunochemistry Analyzers, Organ Function Assays, Anemia / Vitamin Tests, Therapeutic Drug Monitoring, Specific Proteins and Drugs of Abuse / Toxicology. The report also provides company shares and distribution shares data for the overall Immuno Chemistry market in each of the aforementioned countries. The report is also supplemented with global corporate-level profiles of the key market participants with information on key developments, wherever available. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts. The emerging economies, comprising China, India, Brazil, Russia and South Africa, with a significantly large pool of under-served patients, represent the next big opportunity for the leading medical equipment and devices manufacturers. China remains the world’s most populous country and is consequently home to a large patient base. The country is home to more than 120 million people who are aged 65 or older—a population in continuous need of medical care. India, the second most populous country globally, is home to 1.2 billion people, approximately 5% of which are aged 65 or older. It’s estimated that shortly after 2020, India’s population will surpass China, making it the most populous country in the world. As the population continues to grow and people continue to age, the underlying demand for healthcare is also expected to increase. Scope - Market size data for Immuno Chemistry market categories – Disease Specific Immunochemistry, Endocrinology Tests, Immunochemistry Rapid Tests, Immunochemistry Analyzers, Organ Function Assays, Anemia / Vitamin Tests, Therapeutic Drug Monitoring, Specific Proteins and Drugs of Abuse / Toxicology. - Annualized market revenues ($m) data for each of the segments and sub-segments within the nine market categories. Data from 2003 to 2010, forecast forward for seven years to 2017. - 2010 company shares and distribution shares data for the overall Immuno Chemistry market in each of the aforementioned countries. - Global corporate-level profiles of key companies operating within the Immuno Chemistry market in BRICS. - Key players covered include Siemens Healthcare, F. Hoffmann-La Roche Ltd., Abbott Laboratories, Ortho-Clinical Diagnostics Inc., Beckman Coulter, Inc., bioMerieux S.A., Phadia AB, Alere Inc., Bio-Rad Laboratories, Inc., Transasia Bio-Medicals Ltd. and DiaSorin S.p.A. Highlights Reasons to buy - Develop business strategies by identifying the key market categories and segments poised for strong growth. - Develop market-entry and market expansion strategies. - Design competition strategies by identifying who-stands-where in the Immuno Chemistry competitive landscape in BRICS. - Develop capital investment strategies by identifying the key market segments expected to register strong growth in the near future. - What are the key distribution channels and what’s the most preferred mode of product distribution – Identify, understand and capitalize. Report Highlights Siemens Healthcare F. Hoffmann-La Roche Ltd. Abbott Laboratories Ortho-Clinical Diagnostics Inc. Beckman Coulter, Inc. bioMerieux S.A. Phadia AB Alere Inc. Bio-Rad Laboratories, Inc. Transasia Bio-Medicals Ltd. DiaSorin S.p.A Danaher Corporation PerkinElmer, Inc. Trivitron Healthcare Pvt Ltd. Span Diagnostics Ltd. OLYMPUS CORPORATION [Studien Infos ausblenden] |
|||||||||||
|
1 Table of Contents 1 Table of Contents 2 1.1 List of Tables 8 1.2 List of Figures 12 2 Introduction 16 2.1 What Is This Report About? 16 3 Immuno Chemistry in BRICS 17 3.1 Immuno Chemistry, BRICS, Overall Revenue ($m), 2003-2017 17 3.2 Immuno Chemistry, BRICS, Company share (2009-2010) 23 4 Immuno Chemistry In Brazil 25 4.1 Immuno Chemistry, Brazil, Overall Revenue ($m), USD Actual, 2003-2017 25 4.2 Disease Specific Immunochemistry In Brazil 31 4.2.1 Disease Specific Immunochemistry, Brazil, Overall Revenue (2003-2017) 31 4.3 Endocrinology Tests In Brazil 35 4.3.1 Endocrinology Tests, Brazil, Overall Revenue (2003-2017) 35 4.4 Organ Function Assays In Brazil 38 4.4.1 Organ Function Assays, Brazil, Overall Revenue (2003-2017) 38 4.5 Therapeutic Drug Monitoring In Brazil 40 4.5.1 Therapeutic Drug Monitoring, Brazil, Overall Revenue (2003-2017) 40 4.6 Immunochemistry Analyzers In Brazil 44 4.6.1 Immunochemistry Analyzers, Brazil, Overall Revenue (2003-2017) 44 4.7 Specific Proteins In Brazil 48 4.7.1 Specific Proteins, Brazil, Overall Revenue (2003-2017) 48 4.8 Anemia / Vitamin Tests In Brazil 50 4.8.1 Anemia / Vitamin Tests, Brazil, Overall Revenue (2003-2017) 50 4.9 Immunochemistry Rapid Tests In Brazil 52 4.9.1 Immunochemistry Rapid Tests, Brazil, Overall Revenue (2003-2017) 52 4.10 Drugs of Abuse / Toxicology In Brazil 54 4.10.1 Drugs of Abuse / Toxicology, Brazil, Overall Revenue (2003-2017) 54 4.11 Immuno Chemistry, Brazil, Distribution Share (2009-2010) 58 4.12 Immuno Chemistry, Brazil, Company Share (2009-2010) 59 5 Immuno Chemistry In Russian Federation 61 5.1 Immuno Chemistry, Russian Federation, Overall Revenue ($m), USD Actual, 2003-2017 61 5.2 Immunochemistry Analyzers In Russian Federation 67 5.2.1 Immunochemistry Analyzers, Russian Federation, Overall Revenue (2003-2017) 67 5.3 Endocrinology Tests In Russian Federation 71 5.3.1 Endocrinology Tests, Russian Federation, Overall Revenue (2003-2017) 71 5.4 Disease Specific Immunochemistry In Russian Federation 75 5.4.1 Disease Specific Immunochemistry, Russian Federation, Overall Revenue (2003-2017) 75 5.5 Organ Function Assays In Russian Federation 79 5.5.1 Organ Function Assays, Russian Federation, Overall Revenue (2003-2017) 79 5.6 Anemia / Vitamin Tests In Russian Federation 81 5.6.1 Anemia / Vitamin Tests, Russian Federation, Overall Revenue (2003-2017) 81 5.7 Specific Proteins In Russian Federation 83 5.7.1 Specific Proteins, Russian Federation, Overall Revenue (2003-2017) 83 5.8 Therapeutic Drug Monitoring In Russian Federation 85 5.8.1 Therapeutic Drug Monitoring, Russian Federation, Overall Revenue (2003-2017) 85 5.9 Drugs of Abuse / Toxicology In Russian Federation 89 5.9.1 Drugs of Abuse / Toxicology, Russian Federation, Overall Revenue (2003-2017) 89 5.10 Immunochemistry Rapid Tests In Russian Federation 93 5.10.1 Immunochemistry Rapid Tests, Russian Federation, Overall Revenue (2003-2017) 93 5.11 Immuno Chemistry, Russian Federation, Distribution Share (2009-2010) 95 5.12 Immuno Chemistry, Russian Federation, Company Share (2009-2010) 96 6 Immuno Chemistry In India 98 6.1 Immuno Chemistry, India, Overall Revenue ($m), USD Actual, 2003-2017 98 6.2 Endocrinology Tests In India 104 6.2.1 Endocrinology Tests, India, Overall Revenue (2003-2017) 104 6.3 Immunochemistry Rapid Tests In India 108 6.3.1 Immunochemistry Rapid Tests, India, Overall Revenue (2003-2017) 108 6.4 Immunochemistry Analyzers In India 110 6.4.1 Immunochemistry Analyzers, India, Overall Revenue (2003-2017) 110 6.5 Disease Specific Immunochemistry In India 114 6.5.1 Disease Specific Immunochemistry, India, Overall Revenue (2003-2017) 114 6.6 Organ Function Assays In India 118 6.6.1 Organ Function Assays, India, Overall Revenue (2003-2017) 118 6.7 Anemia / Vitamin Tests In India 120 6.7.1 Anemia / Vitamin Tests, India, Overall Revenue (2003-2017) 120 6.8 Drugs of Abuse / Toxicology In India 122 6.8.1 Drugs of Abuse / Toxicology, India, Overall Revenue (2003-2017) 122 6.9 Specific Proteins In India 126 6.9.1 Specific Proteins, India, Overall Revenue (2003-2017) 126 6.10 Therapeutic Drug Monitoring In India 128 6.10.1 Therapeutic Drug Monitoring, India, Overall Revenue (2003-2017) 128 6.11 Immuno Chemistry, India, Distribution Share (2009-2010) 132 6.12 Immuno Chemistry, India, Company Share (2009-2010) 133 7 Immuno Chemistry In China 135 7.1.1 Immuno Chemistry, China, Overall Revenue ($m), USD Actual, 2003-2017 135 7.2 Disease Specific Immunochemistry In China 141 7.2.1 Disease Specific Immunochemistry, China, Overall Revenue (2003-2017) 141 7.3 Immunochemistry Rapid Tests In China 145 7.3.1 Immunochemistry Rapid Tests, China, Overall Revenue (2003-2017) 145 7.4 Endocrinology Tests In China 147 7.4.1 Endocrinology Tests, China, Overall Revenue (2003-2017) 147 7.5 Immunochemistry Analyzers In China 151 7.5.1 Immunochemistry Analyzers, China, Overall Revenue (2003-2017) 151 7.6 Organ Function Assays In China 155 7.6.1 Organ Function Assays, China, Overall Revenue (2003-2017) 155 7.7 Anemia / Vitamin Tests In China 157 7.7.1 Anemia / Vitamin Tests, China, Overall Revenue (2003-2017) 157 7.8 Specific Proteins In China 159 7.8.1 Specific Proteins, China, Overall Revenue (2003-2017) 159 7.9 Therapeutic Drug Monitoring In China 161 7.9.1 Therapeutic Drug Monitoring, China, Overall Revenue (2003-2017) 161 7.10 Drugs of Abuse / Toxicology In China 165 7.10.1 Drugs of Abuse / Toxicology, China, Overall Revenue (2003-2017) 165 7.11 Immuno Chemistry, China, Distribution Share (2009-2010) 169 7.12 Immuno Chemistry, China, Company Share (2009-2010) 170 8 Immuno Chemistry In South Africa 172 8.1 Immuno Chemistry, South Africa, Overall Revenue ($m), USD Actual, 2003-2017 172 8.2 Disease Specific Immunochemistry In South Africa 178 8.2.1 Disease Specific Immunochemistry, South Africa, Overall Revenue (2003-2017) 178 8.3 Immunochemistry Analyzers In South Africa 182 8.3.1 Immunochemistry Analyzers, South Africa, Overall Revenue (2003-2017) 182 8.4 Organ Function Assays In South Africa 186 8.4.1 Organ Function Assays, South Africa, Overall Revenue (2003-2017) 186 8.5 Endocrinology Tests In South Africa 188 8.5.1 Endocrinology Tests, South Africa, Overall Revenue (2003-2017) 188 8.6 Immunochemistry Rapid Tests In South Africa 192 8.6.1 Immunochemistry Rapid Tests, South Africa, Overall Revenue (2003-2017) 192 8.7 Specific Proteins In South Africa 194 8.7.1 Specific Proteins, South Africa, Overall Revenue (2003-2017) 194 8.8 Therapeutic Drug Monitoring In South Africa 196 8.8.1 Therapeutic Drug Monitoring, South Africa, Overall Revenue (2003-2017) 196 8.9 Anemia / Vitamin Tests In South Africa 200 8.9.1 Anemia / Vitamin Tests, South Africa, Overall Revenue (2003-2017) 200 8.10 Drugs of Abuse / Toxicology In South Africa 202 8.10.1 Drugs of Abuse / Toxicology, South Africa, Overall Revenue (2003-2017) 202 8.11 Immuno Chemistry, South Africa, Distribution Share (2009-2010) 206 8.12 Immuno Chemistry, South Africa, Company Share (2009-2010) 207 9 Overview of Key Companies in BRICS Immuno Chemistry Market 209 9.1 Siemens Healthcare 209 9.1.1 Company Overview 209 9.1.2 Share in the BRICS Immuno Chemistry Market 210 9.2 F. Hoffmann-La Roche Ltd. 211 9.2.1 Company Overview 211 9.2.2 Share in the BRICS Immuno Chemistry Market 212 9.3 Abbott Laboratories 214 9.3.1 Company Overview 214 9.3.2 Share in the BRICS Immuno Chemistry Market 215 9.4 Ortho-Clinical Diagnostics Inc. 217 9.4.1 Company Overview 217 9.4.2 Share in the BRICS Immuno Chemistry Market 217 9.5 Beckman Coulter, Inc. 219 9.5.1 Company Overview 219 9.5.2 Share in the BRICS Immuno Chemistry Market 220 9.6 bioMerieux S.A. 222 9.6.1 Company Overview 222 9.6.2 Share in the BRICS Immuno Chemistry Market 223 9.7 Phadia AB 225 9.7.1 Company Overview 225 9.7.2 Share in the BRICS Immuno Chemistry Market 226 9.8 Alere Inc. 228 9.8.1 Company Overview 228 9.8.2 Share in the BRICS Immuno Chemistry Market 229 9.9 Bio-Rad Laboratories, Inc. 231 9.9.1 Company Overview 231 9.9.2 Share in the BRICS Immuno Chemistry Market 232 9.10 Transasia Bio-Medicals Ltd. 234 9.10.1 Company Overview 234 9.11 DiaSorin S.p.A 235 9.11.1 Company Overview 235 9.11.2 Share in the BRICS Immuno Chemistry Market 236 9.12 Danaher Corporation 238 9.12.1 Company Overview 238 9.13 PerkinElmer, Inc. 238 9.13.1 Company Overview 238 9.14 Trivitron Healthcare Pvt Ltd. 238 9.14.1 Company Overview 238 9.15 Span Diagnostics Ltd. 239 9.15.1 Company Overview 239 9.16 OLYMPUS CORPORATION 239 9.16.1 Company Overview 239 10 Appendix 240 10.1 Definitions of Markets Covered in the Report 241 10.1.1 Immuno Chemistry 241 10.2 Research Methodology 245 10.3 Secondary Research 245 10.4 Primary Research 246 10.5 Models 246 10.6 Forecasts 247 10.7 Expert Panels 247 10.8 GlobalData Consulting 247 10.9 Currency Conversion 248 10.10 Contact Us 248 10.11 Disclaimer 248 [Inhaltsverzeichnis ausblenden] |
||||||||||||
|
1.1 List of Tables Table 1: Immuno Chemistry, BRICS, Overall Revenue ($m), 2003-2017 18 Table 2: Immuno Chemistry, BRICS, Overall Revenue ($m), Historic, 2003-2010 20 Table 3: Immuno Chemistry, BRICS, Overall Revenue ($m), Forecast, 2010-2017 22 Table 4: Immuno Chemistry, BRICS, Company share by Revenue ($m), USD Actual, 2009-2010 24 Table 5: Immuno Chemistry, Brazil, Overall Revenue ($m), USD Actual, 2003-2017 26 Table 6: Immuno Chemistry, Brazil, Overall Revenue ($m), USD Actual, Historic, 2003-2010 28 Table 7: Immuno Chemistry, Brazil, Overall Revenue ($m), USD Actual, Forecast, 2010-2017 30 Table 8: Disease Specific Immunochemistry, Brazil, Revenue ($m) by Segment, Historic, 2003-2010 32 Table 9: Disease Specific Immunochemistry, Brazil, Revenue ($m) by Segment, Forecast, 2010-2017 34 Table 10: Endocrinology Tests, Brazil, Revenue ($m) by Segment, Historic, 2003-2010 36 Table 11: Endocrinology Tests, Brazil, Revenue ($m) by Segment, Forecast, 2010-2017 37 Table 12: Organ Function Assays, Brazil, Revenue ($m), Historic, 2003-2010 38 Table 13: Organ Function Assays, Brazil, Revenue ($m), Forecast, 2010-2017 39 Table 14: Therapeutic Drug Monitoring, Brazil, Revenue ($m) by Segment, Historic, 2003-2010 41 Table 15: Therapeutic Drug Monitoring, Brazil, Revenue ($m) by Segment, Forecast, 2010-2017 43 Table 16: Immunochemistry Analyzers, Brazil, Revenue ($m) by Segment, Historic, 2003-2010 45 Table 17: Immunochemistry Analyzers, Brazil, Revenue ($m) by Segment, Forecast, 2010-2017 47 Table 18: Specific Proteins, Brazil, Revenue ($m), Historic, 2003-2010 48 Table 19: Specific Proteins, Brazil, Revenue ($m), Forecast, 2010-2017 49 Table 20: Anemia / Vitamin Tests, Brazil, Revenue ($m), Historic, 2003-2010 50 Table 21: Anemia / Vitamin Tests, Brazil, Revenue ($m), Forecast, 2010-2017 51 Table 22: Immunochemistry Rapid Tests, Brazil, Revenue ($m), Historic, 2003-2010 52 Table 23: Immunochemistry Rapid Tests, Brazil, Revenue ($m), Forecast, 2010-2017 53 Table 24: Drugs of Abuse / Toxicology, Brazil, Revenue ($m) by Segment, Historic, 2003-2010 55 Table 25: Drugs of Abuse / Toxicology, Brazil, Revenue ($m) by Segment, Forecast, 2010-2017 57 Table 26: Immuno Chemistry, Brazil, Distribution Share by Revenue ($m), USD Actual, 2009-2010 58 Table 27: Immuno Chemistry, Brazil, Company share by Revenue ($m), USD Actual, 2009-2010 60 Table 28: Immuno Chemistry, Russian Federation, Overall Revenue ($m), USD Actual, 2003-2017 62 Table 29: Immuno Chemistry, Russian Federation, Overall Revenue ($m), USD Actual, Historic, 2003-2010 64 Table 30: Immuno Chemistry, Russian Federation, Overall Revenue ($m), USD Actual, Forecast, 2010-2017 66 Table 31: Immunochemistry Analyzers, Russian Federation, Revenue ($m) by Segment, Historic, 2003-2010 68 Table 32: Immunochemistry Analyzers, Russian Federation, Revenue ($m) by Segment, Forecast, 2010-2017 70 Table 33: Endocrinology Tests, Russian Federation, Revenue ($m) by Segment, Historic, 2003-2010 72 Table 34: Endocrinology Tests, Russian Federation, Revenue ($m) by Segment, Forecast, 2010-2017 74 Table 35: Disease Specific Immunochemistry, Russian Federation, Revenue ($m) by Segment, Historic, 2003-2010 76 Table 36: Disease Specific Immunochemistry, Russian Federation, Revenue ($m) by Segment, Forecast, 2010-2017 78 Table 37: Organ Function Assays, Russian Federation, Revenue ($m), Historic, 2003-2010 79 Table 38: Organ Function Assays, Russian Federation, Revenue ($m), Forecast, 2010-2017 80 Table 39: Anemia / Vitamin Tests, Russian Federation, Revenue ($m), Historic, 2003-2010 81 Table 40: Anemia / Vitamin Tests, Russian Federation, Revenue ($m), Forecast, 2010-2017 82 Table 41: Specific Proteins, Russian Federation, Revenue ($m), Historic, 2003-2010 83 Table 42: Specific Proteins, Russian Federation, Revenue ($m), Forecast, 2010-2017 84 Table 43: Therapeutic Drug Monitoring, Russian Federation, Revenue ($m) by Segment, Historic, 2003-2010 86 Table 44: Therapeutic Drug Monitoring, Russian Federation, Revenue ($m) by Segment, Forecast, 2010-2017 88 Table 45: Drugs of Abuse / Toxicology, Russian Federation, Revenue ($m) by Segment, Historic, 2003-2010 90 Table 46: Drugs of Abuse / Toxicology, Russian Federation, Revenue ($m) by Segment, Forecast, 2010-2017 92 Table 47: Immunochemistry Rapid Tests, Russian Federation, Revenue ($m), Historic, 2003-2010 93 Table 48: Immunochemistry Rapid Tests, Russian Federation, Revenue ($m), Forecast, 2010-2017 94 Table 49: Immuno Chemistry, Russian Federation, Distribution Share by Revenue ($m), USD Actual, 2009-2010 95 Table 50: Immuno Chemistry, Russian Federation, Company share by Revenue ($m), USD Actual, 2009-2010 97 Table 51: Immuno Chemistry, India, Overall Revenue ($m), USD Actual, 2003-2017 99 Table 52: Immuno Chemistry, India, Overall Revenue ($m), USD Actual, Historic, 2003-2010 101 Table 53: Immuno Chemistry, India, Overall Revenue ($m), USD Actual, Forecast, 2010-2017 103 Table 54: Endocrinology Tests, India, Revenue ($m) by Segment, Historic, 2003-2010 105 Table 55: Endocrinology Tests, India, Revenue ($m) by Segment, Forecast, 2010-2017 107 Table 56: Immunochemistry Rapid Tests, India, Revenue ($m), Historic, 2003-2010 108 Table 57: Immunochemistry Rapid Tests, India, Revenue ($m), Forecast, 2010-2017 109 Table 58: Immunochemistry Analyzers, India, Revenue ($m) by Segment, Historic, 2003-2010 111 Table 59: Immunochemistry Analyzers, India, Revenue ($m) by Segment, Forecast, 2010-2017 113 Table 60: Disease Specific Immunochemistry, India, Revenue ($m) by Segment, Historic, 2003-2010 115 Table 61: Disease Specific Immunochemistry, India, Revenue ($m) by Segment, Forecast, 2010-2017 117 Table 62: Organ Function Assays, India, Revenue ($m), Historic, 2003-2010 118 Table 63: Organ Function Assays, India, Revenue ($m), Forecast, 2010-2017 119 Table 64: Anemia / Vitamin Tests, India, Revenue ($m), Historic, 2003-2010 120 Table 65: Anemia / Vitamin Tests, India, Revenue ($m), Forecast, 2010-2017 121 Table 66: Drugs of Abuse / Toxicology, India, Revenue ($m) by Segment, Historic, 2003-2010 123 Table 67: Drugs of Abuse / Toxicology, India, Revenue ($m) by Segment, Forecast, 2010-2017 125 Table 68: Specific Proteins, India, Revenue ($m), Historic, 2003-2010 126 Table 69: Specific Proteins, India, Revenue ($m), Forecast, 2010-2017 127 Table 70: Therapeutic Drug Monitoring, India, Revenue ($m) by Segment, Historic, 2003-2010 129 Table 71: Therapeutic Drug Monitoring, India, Revenue ($m) by Segment, Forecast, 2010-2017 131 Table 72: Immuno Chemistry, India, Distribution Share by Revenue ($m), USD Actual, 2009-2010 132 Table 73: Immuno Chemistry, India, Company share by Revenue ($m), USD Actual, 2009-2010 134 Table 74: Immuno Chemistry, China, Overall Revenue ($m), USD Actual, 2003-2017 136 Table 75: Immuno Chemistry, China, Overall Revenue ($m), USD Actual, Historic, 2003-2010 138 Table 76: Immuno Chemistry, China, Overall Revenue ($m), USD Actual, Forecast, 2010-2017 140 Table 77: Disease Specific Immunochemistry, China, Revenue ($m) by Segment, Historic, 2003-2010 142 Table 78: Disease Specific Immunochemistry, China, Revenue ($m) by Segment, Forecast, 2010-2017 144 Table 79: Immunochemistry Rapid Tests, China, Revenue ($m), Historic, 2003-2010 145 Table 80: Immunochemistry Rapid Tests, China, Revenue ($m), Forecast, 2010-2017 146 Table 81: Endocrinology Tests, China, Revenue ($m) by Segment, Historic, 2003-2010 148 Table 82: Endocrinology Tests, China, Revenue ($m) by Segment, Forecast, 2010-2017 150 Table 83: Immunochemistry Analyzers, China, Revenue ($m) by Segment, Historic, 2003-2010 152 Table 84: Immunochemistry Analyzers, China, Revenue ($m) by Segment, Forecast, 2010-2017 154 Table 85: Organ Function Assays, China, Revenue ($m), Historic, 2003-2010 155 Table 86: Organ Function Assays, China, Revenue ($m), Forecast, 2010-2017 156 Table 87: Anemia / Vitamin Tests, China, Revenue ($m), Historic, 2003-2010 157 Table 88: Anemia / Vitamin Tests, China, Revenue ($m), Forecast, 2010-2017 158 Table 89: Specific Proteins, China, Revenue ($m), Historic, 2003-2010 159 Table 90: Specific Proteins, China, Revenue ($m), Forecast, 2010-2017 160 Table 91: Therapeutic Drug Monitoring, China, Revenue ($m) by Segment, Historic, 2003-2010 162 Table 92: Therapeutic Drug Monitoring, China, Revenue ($m) by Segment, Forecast, 2010-2017 164 Table 93: Drugs of Abuse / Toxicology, China, Revenue ($m) by Segment, Historic, 2003-2010 166 Table 94: Drugs of Abuse / Toxicology, China, Revenue ($m) by Segment, Forecast, 2010-2017 168 Table 95: Immuno Chemistry, China, Distribution Share by Revenue ($m), USD Actual, 2009-2010 169 Table 96: Immuno Chemistry, China, Company share by Revenue ($m), USD Actual, 2009-2010 171 Table 97: Immuno Chemistry, South Africa, Overall Revenue ($m), USD Actual, 2003-2017 173 Table 98: Immuno Chemistry, South Africa, Overall Revenue ($m), USD Actual, Historic, 2003-2010 175 Table 99: Immuno Chemistry, South Africa, Overall Revenue ($m), USD Actual, Forecast, 2010-2017 177 Table 100: Disease Specific Immunochemistry, South Africa, Revenue ($m) by Segment, Historic, 2003-2010 179 Table 101: Disease Specific Immunochemistry, South Africa, Revenue ($m) by Segment, Forecast, 2010-2017 181 Table 102: Immunochemistry Analyzers, South Africa, Revenue ($m) by Segment, Historic, 2003-2010 183 Table 103: Immunochemistry Analyzers, South Africa, Revenue ($m) by Segment, Forecast, 2010-2017 185 Table 104: Organ Function Assays, South Africa, Revenue ($m), Historic, 2003-2010 186 Table 105: Organ Function Assays, South Africa, Revenue ($m), Forecast, 2010-2017 187 Table 106: Endocrinology Tests, South Africa, Revenue ($m) by Segment, Historic, 2003-2010 189 Table 107: Endocrinology Tests, South Africa, Revenue ($m) by Segment, Forecast, 2010-2017 191 Table 108: Immunochemistry Rapid Tests, South Africa, Revenue ($m), Historic, 2003-2010 192 Table 109: Immunochemistry Rapid Tests, South Africa, Revenue ($m), Forecast, 2010-2017 193 Table 110: Specific Proteins, South Africa, Revenue ($m), Historic, 2003-2010 194 Table 111: Specific Proteins, South Africa, Revenue ($m), Forecast, 2010-2017 195 Table 112: Therapeutic Drug Monitoring, South Africa, Revenue ($m) by Segment, Historic, 2003-2010 197 Table 113: Therapeutic Drug Monitoring, South Africa, Revenue ($m) by Segment, Forecast, 2010-2017 199 Table 114: Anemia / Vitamin Tests, South Africa, Revenue ($m), Historic, 2003-2010 200 Table 115: Anemia / Vitamin Tests, South Africa, Revenue ($m), Forecast, 2010-2017 201 Table 116: Drugs of Abuse / Toxicology, South Africa, Revenue ($m) by Segment, Historic, 2003-2010 203 Table 117: Drugs of Abuse / Toxicology, South Africa, Revenue ($m) by Segment, Forecast, 2010-2017 205 Table 118: Immuno Chemistry, South Africa, Distribution Share by Revenue ($m), USD Actual, 2009-2010 206 Table 119: Immuno Chemistry, South Africa, Company share by Revenue ($m), USD Actual, 2009-2010 208 Table 120: Siemens Healthcare, Revenue ($m), BRICS Immuno Chemistry Market, 2010 210 Table 121: F. Hoffmann-La Roche Ltd., Revenue ($m), BRICS Immuno Chemistry Market, 2010 213 Table 122: Abbott Laboratories, Revenue ($m), BRICS Immuno Chemistry Market, 2010 216 Table 123: Ortho-Clinical Diagnostics Inc., Revenue ($m), BRICS Immuno Chemistry Market, 2010 218 Table 124: Beckman Coulter, Inc., Revenue ($m), BRICS Immuno Chemistry Market, 2010 221 Table 125: bioMerieux S.A., Revenue ($m), BRICS Immuno Chemistry Market, 2010 224 Table 126: Phadia AB, Revenue ($m), BRICS Immuno Chemistry Market, 2010 227 Table 127: Alere Inc., Revenue ($m), BRICS Immuno Chemistry Market, 2010 230 Table 128: Bio-Rad Laboratories, Inc., Revenue ($m), BRICS Immuno Chemistry Market, 2010 233 Table 129: Transasia Bio-Medicals Ltd., Revenue ($m), BRICS Immuno Chemistry Market, 2010 234 Table 130: DiaSorin S.p.A, Revenue ($m), BRICS Immuno Chemistry Market, 2010 237 Table 131: USD to Local Currency, BRICS, Average Exchange Rate, 2003-2010 248 1.2 List of Figures Figure 1: Immuno Chemistry, BRICS, Overall Revenue ($m), 2003-2017 17 Figure 2: Immuno Chemistry, BRICS, Overall Revenue ($m), Historic, 2003-2010 19 Figure 3: Immuno Chemistry, BRICS, Overall Revenue ($m), Forecast, 2010-2017 21 Figure 4: Immuno Chemistry, BRICS, Company share (%), 2010 23 Figure 5: Immuno Chemistry, Brazil, Overall Revenue ($m), USD Actual, 2003-2017 25 Figure 6: Immuno Chemistry, Brazil, Overall Revenue ($m), USD Actual, Historic, 2003-2010 27 Figure 7: Immuno Chemistry, Brazil, Overall Revenue ($m), USD Actual, Forecast, 2010-2017 29 Figure 8: Disease Specific Immunochemistry, Brazil, Revenue ($m) by Segment, Historic, 2003-2010 31 Figure 9: Disease Specific Immunochemistry, Brazil, Revenue ($m) by Segment, Forecast, 2010-2017 33 Figure 10: Endocrinology Tests, Brazil, Revenue ($m) by Segment, Historic, 2003-2010 35 Figure 11: Endocrinology Tests, Brazil, Revenue ($m) by Segment, Forecast, 2010-2017 37 Figure 12: Organ Function Assays, Brazil, Revenue ($m), Historic, 2003-2010 38 Figure 13: Organ Function Assays, Brazil, Revenue ($m), Forecast, 2010-2017 39 Figure 14: Therapeutic Drug Monitoring, Brazil, Revenue ($m) by Segment, Historic, 2003-2010 40 Figure 15: Therapeutic Drug Monitoring, Brazil, Revenue ($m) by Segment, Forecast, 2010-2017 42 Figure 16: Immunochemistry Analyzers, Brazil, Revenue ($m) by Segment, Historic, 2003-2010 44 Figure 17: Immunochemistry Analyzers, Brazil, Revenue ($m) by Segment, Forecast, 2010-2017 46 Figure 18: Specific Proteins, Brazil, Revenue ($m), Historic, 2003-2010 48 Figure 19: Specific Proteins, Brazil, Revenue ($m), Forecast, 2010-2017 49 Figure 20: Anemia / Vitamin Tests, Brazil, Revenue ($m), Historic, 2003-2010 50 Figure 21: Anemia / Vitamin Tests, Brazil, Revenue ($m), Forecast, 2010-2017 51 Figure 22: Immunochemistry Rapid Tests, Brazil, Revenue ($m), Historic, 2003-2010 52 Figure 23: Immunochemistry Rapid Tests, Brazil, Revenue ($m), Forecast, 2010-2017 53 Figure 24: Drugs of Abuse / Toxicology, Brazil, Revenue ($m) by Segment, Historic, 2003-2010 54 Figure 25: Drugs of Abuse / Toxicology, Brazil, Revenue ($m) by Segment, Forecast, 2010-2017 56 Figure 26: Immuno Chemistry, Brazil, Company share (%), 2010 59 Figure 27: Immuno Chemistry, Russian Federation, Overall Revenue ($m), USD Actual, 2003-2017 61 Figure 28: Immuno Chemistry, Russian Federation, Overall Revenue ($m), USD Actual, Historic, 2003-2010 63 Figure 29: Immuno Chemistry, Russian Federation, Overall Revenue ($m), USD Actual, Forecast, 2010-2017 65 Figure 30: Immunochemistry Analyzers, Russian Federation, Revenue ($m) by Segment, Historic, 2003-2010 67 Figure 31: Immunochemistry Analyzers, Russian Federation, Revenue ($m) by Segment, Forecast, 2010-2017 69 Figure 32: Endocrinology Tests, Russian Federation, Revenue ($m) by Segment, Historic, 2003-2010 71 Figure 33: Endocrinology Tests, Russian Federation, Revenue ($m) by Segment, Forecast, 2010-2017 73 Figure 34: Disease Specific Immunochemistry, Russian Federation, Revenue ($m) by Segment, Historic, 2003-2010 75 Figure 35: Disease Specific Immunochemistry, Russian Federation, Revenue ($m) by Segment, Forecast, 2010-2017 77 Figure 36: Organ Function Assays, Russian Federation, Revenue ($m), Historic, 2003-2010 79 Figure 37: Organ Function Assays, Russian Federation, Revenue ($m), Forecast, 2010-2017 80 Figure 38: Anemia / Vitamin Tests, Russian Federation, Revenue ($m), Historic, 2003-2010 81 Figure 39: Anemia / Vitamin Tests, Russian Federation, Revenue ($m), Forecast, 2010-2017 82 Figure 40: Specific Proteins, Russian Federation, Revenue ($m), Historic, 2003-2010 83 Figure 41: Specific Proteins, Russian Federation, Revenue ($m), Forecast, 2010-2017 84 Figure 42: Therapeutic Drug Monitoring, Russian Federation, Revenue ($m) by Segment, Historic, 2003-2010 85 Figure 43: Therapeutic Drug Monitoring, Russian Federation, Revenue ($m) by Segment, Forecast, 2010-2017 87 Figure 44: Drugs of Abuse / Toxicology, Russian Federation, Revenue ($m) by Segment, Historic, 2003-2010 89 Figure 45: Drugs of Abuse / Toxicology, Russian Federation, Revenue ($m) by Segment, Forecast, 2010-2017 91 Figure 46: Immunochemistry Rapid Tests, Russian Federation, Revenue ($m), Historic, 2003-2010 93 Figure 47: Immunochemistry Rapid Tests, Russian Federation, Revenue ($m), Forecast, 2010-2017 94 Figure 48: Immuno Chemistry, Russian Federation, Company share (%), 2010 96 Figure 49: Immuno Chemistry, India, Overall Revenue ($m), USD Actual, 2003-2017 98 Figure 50: Immuno Chemistry, India, Overall Revenue ($m), USD Actual, Historic, 2003-2010 100 Figure 51: Immuno Chemistry, India, Overall Revenue ($m), USD Actual, Forecast, 2010-2017 102 Figure 52: Endocrinology Tests, India, Revenue ($m) by Segment, Historic, 2003-2010 104 Figure 53: Endocrinology Tests, India, Revenue ($m) by Segment, Forecast, 2010-2017 106 Figure 54: Immunochemistry Rapid Tests, India, Revenue ($m), Historic, 2003-2010 108 Figure 55: Immunochemistry Rapid Tests, India, Revenue ($m), Forecast, 2010-2017 109 Figure 56: Immunochemistry Analyzers, India, Revenue ($m) by Segment, Historic, 2003-2010 110 Figure 57: Immunochemistry Analyzers, India, Revenue ($m) by Segment, Forecast, 2010-2017 112 Figure 58: Disease Specific Immunochemistry, India, Revenue ($m) by Segment, Historic, 2003-2010 114 Figure 59: Disease Specific Immunochemistry, India, Revenue ($m) by Segment, Forecast, 2010-2017 116 Figure 60: Organ Function Assays, India, Revenue ($m), Historic, 2003-2010 118 Figure 61: Organ Function Assays, India, Revenue ($m), Forecast, 2010-2017 119 Figure 62: Anemia / Vitamin Tests, India, Revenue ($m), Historic, 2003-2010 120 Figure 63: Anemia / Vitamin Tests, India, Revenue ($m), Forecast, 2010-2017 121 Figure 64: Drugs of Abuse / Toxicology, India, Revenue ($m) by Segment, Historic, 2003-2010 122 Figure 65: Drugs of Abuse / Toxicology, India, Revenue ($m) by Segment, Forecast, 2010-2017 124 Figure 66: Specific Proteins, India, Revenue ($m), Historic, 2003-2010 126 Figure 67: Specific Proteins, India, Revenue ($m), Forecast, 2010-2017 127 Figure 68: Therapeutic Drug Monitoring, India, Revenue ($m) by Segment, Historic, 2003-2010 128 Figure 69: Therapeutic Drug Monitoring, India, Revenue ($m) by Segment, Forecast, 2010-2017 130 Figure 70: Immuno Chemistry, India, Company share (%), 2010 133 Figure 71: Immuno Chemistry, China, Overall Revenue ($m), USD Actual, 2003-2017 135 Figure 72: Immuno Chemistry, China, Overall Revenue ($m), USD Actual, Historic, 2003-2010 137 Figure 73: Immuno Chemistry, China, Overall Revenue ($m), USD Actual, Forecast, 2010-2017 139 Figure 74: Disease Specific Immunochemistry, China, Revenue ($m) by Segment, Historic, 2003-2010 141 Figure 75: Disease Specific Immunochemistry, China, Revenue ($m) by Segment, Forecast, 2010-2017 143 Figure 76: Immunochemistry Rapid Tests, China, Revenue ($m), Historic, 2003-2010 145 Figure 77: Immunochemistry Rapid Tests, China, Revenue ($m), Forecast, 2010-2017 146 Figure 78: Endocrinology Tests, China, Revenue ($m) by Segment, Historic, 2003-2010 147 Figure 79: Endocrinology Tests, China, Revenue ($m) by Segment, Forecast, 2010-2017 149 Figure 80: Immunochemistry Analyzers, China, Revenue ($m) by Segment, Historic, 2003-2010 151 Figure 81: Immunochemistry Analyzers, China, Revenue ($m) by Segment, Forecast, 2010-2017 153 Figure 82: Organ Function Assays, China, Revenue ($m), Historic, 2003-2010 155 Figure 83: Organ Function Assays, China, Revenue ($m), Forecast, 2010-2017 156 Figure 84: Anemia / Vitamin Tests, China, Revenue ($m), Historic, 2003-2010 157 Figure 85: Anemia / Vitamin Tests, China, Revenue ($m), Forecast, 2010-2017 158 Figure 86: Specific Proteins, China, Revenue ($m), Historic, 2003-2010 159 Figure 87: Specific Proteins, China, Revenue ($m), Forecast, 2010-2017 160 Figure 88: Therapeutic Drug Monitoring, China, Revenue ($m) by Segment, Historic, 2003-2010 161 Figure 89: Therapeutic Drug Monitoring, China, Revenue ($m) by Segment, Forecast, 2010-2017 163 Figure 90: Drugs of Abuse / Toxicology, China, Revenue ($m) by Segment, Historic, 2003-2010 165 Figure 91: Drugs of Abuse / Toxicology, China, Revenue ($m) by Segment, Forecast, 2010-2017 167 Figure 92: Immuno Chemistry, China, Company share (%), 2010 170 Figure 93: Immuno Chemistry, South Africa, Overall Revenue ($m), USD Actual, 2003-2017 172 Figure 94: Immuno Chemistry, South Africa, Overall Revenue ($m), USD Actual, Historic, 2003-2010 174 Figure 95: Immuno Chemistry, South Africa, Overall Revenue ($m), USD Actual, Forecast, 2010-2017 176 Figure 96: Disease Specific Immunochemistry, South Africa, Revenue ($m) by Segment, Historic, 2003-2010 178 Figure 97: Disease Specific Immunochemistry, South Africa, Revenue ($m) by Segment, Forecast, 2010-2017 180 Figure 98: Immunochemistry Analyzers, South Africa, Revenue ($m) by Segment, Historic, 2003-2010 182 Figure 99: Immunochemistry Analyzers, South Africa, Revenue ($m) by Segment, Forecast, 2010-2017 184 Figure 100: Organ Function Assays, South Africa, Revenue ($m), Historic, 2003-2010 186 Figure 101: Organ Function Assays, South Africa, Revenue ($m), Forecast, 2010-2017 187 Figure 102: Endocrinology Tests, South Africa, Revenue ($m) by Segment, Historic, 2003-2010 188 Figure 103: Endocrinology Tests, South Africa, Revenue ($m) by Segment, Forecast, 2010-2017 190 Figure 104: Immunochemistry Rapid Tests, South Africa, Revenue ($m), Historic, 2003-2010 192 Figure 105: Immunochemistry Rapid Tests, South Africa, Revenue ($m), Forecast, 2010-2017 193 Figure 106: Specific Proteins, South Africa, Revenue ($m), Historic, 2003-2010 194 Figure 107: Specific Proteins, South Africa, Revenue ($m), Forecast, 2010-2017 195 Figure 108: Therapeutic Drug Monitoring, South Africa, Revenue ($m) by Segment, Historic, 2003-2010 196 Figure 109: Therapeutic Drug Monitoring, South Africa, Revenue ($m) by Segment, Forecast, 2010-2017 198 Figure 110: Anemia / Vitamin Tests, South Africa, Revenue ($m), Historic, 2003-2010 200 Figure 111: Anemia / Vitamin Tests, South Africa, Revenue ($m), Forecast, 2010-2017 201 Figure 112: Drugs of Abuse / Toxicology, South Africa, Revenue ($m) by Segment, Historic, 2003-2010 202 Figure 113: Drugs of Abuse / Toxicology, South Africa, Revenue ($m) by Segment, Forecast, 2010-2017 204 Figure 114: Immuno Chemistry, South Africa, Company share (%), 2010 207 Figure 115: Siemens Healthcare, Company Share (%), BRICS Immuno Chemistry Market, 2010 210 Figure 116: F. Hoffmann-La Roche Ltd., Company Share (%), BRICS Immuno Chemistry Market, 2010 212 Figure 117: Abbott Laboratories, Company Share (%), BRICS Immuno Chemistry Market, 2010 215 Figure 118: Ortho-Clinical Diagnostics Inc., Company Share (%), BRICS Immuno Chemistry Market, 2010 217 Figure 119: Beckman Coulter, Inc., Company Share (%), BRICS Immuno Chemistry Market, 2010 220 Figure 120: bioMerieux S.A., Company Share (%), BRICS Immuno Chemistry Market, 2010 223 Figure 121: Phadia AB, Company Share (%), BRICS Immuno Chemistry Market, 2010 226 Figure 122: Alere Inc., Company Share (%), BRICS Immuno Chemistry Market, 2010 229 Figure 123: Bio-Rad Laboratories, Inc., Company Share (%), BRICS Immuno Chemistry Market, 2010 232 Figure 124: DiaSorin S.p.A, Company Share (%), BRICS Immuno Chemistry Market, 2010 236 [Tabellenverzeichnis ausblenden] |
||||||||||||
| Hinweis: | * Der Rechnungsbetrag für diese Studie wird in $ (Dollar) ausgewiesen. Kunden aus dem Inland bekommen von uns eine Rechnung in Euro, umgerechnet zum letztwöchigen Schlusskurs | |||||||||||
|
|
||||||||||||
